Sustained improvement in health-related quality of life outcomes in patients with Ulcerative Colitis with long-term tofacitinib treatment in the open-label extension study, OCTAVE Open

被引：0

作者：

Biedermann, L. ^{[1
]}

Dubinsky, M. C. ^{[2
]}

Vermeire, S. ^{[3
]}

Fellmann, M. ^{[4
]}

Gardiner, S. ^{[5
]}

Hur, P. ^{[5
]}

Mundayat, R.

Panes, J. ^{[6
]}

Rubin, D. T. ^{[7
]}

机构：

[1] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Zurich, Switzerland

[2] Icahn Sch Med Mt Sinai, New York, NY USA

[3] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium

[4] Pfizer Switzerland AG, Zurich, Switzerland

[5] Pfizer Inc, New York, NY USA

[6] Hosp Clin Barcelona IDIBAPS CIBERehd, Dept Gastroenterol, Barcelona, Spain

[7] Univ Chicago, Med Inflammatory Bowel Dis Ctr, Chicago, IL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P286

引用

页码：I317 / I319

页数：5